DARA RVD For High Risk SMM
Summary
Third Opinion Trial Synopsis:
This research study wants to find out if using four drugs (Darzalex Faspro, Velcade, Revlimid, and Dexamethasone) together can help treat smoldering multiple myeloma and stop it from getting worse.
This research study wants to find out if using four drugs (Darzalex Faspro, Velcade, Revlimid, and Dexamethasone) together can help treat smoldering multiple myeloma and stop it from getting worse.
*Third Opinion AI Generated Synopsis
Trial Summary
The purpose of this research study is to learn whether the combination of daratumumab SC ( Darzalex Faspro), lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone works in treating smoldering multiple myeloma and preventing progression to active or symptomatic multiple myeloma. The names of the study drugs involved in this study are: Daratumumab (also called Darzalex Faspro) Bortezomib (also called Velcade) Lenalidomide (also called Revlimid) Dexamethasone
The purpose of this research study is to learn whether the combination of daratumumab SC ( Darzalex Faspro), lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone works in treating smoldering multiple myeloma and preventing progression to active or symptomatic multiple myeloma. The names of the study drugs involved in this study are: Daratumumab (also called Darzalex Faspro) Bortezomib (also called Velcade) Lenalidomide (also called Revlimid) Dexamethasone
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: